XML 101 R83.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS' EQUITY AND SHARE INCENTIVE PLANS, Share Option Activity (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Nov. 21, 2023
USD ($)
Jan. 17, 2023
shares
Jan. 31, 2023
$ / shares
shares
Oct. 31, 2020
$ / shares
Dec. 31, 2023
USD ($)
Vote
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
Dec. 30, 2022
shares
Stock Option Plan [Abstract]                
Vote per share | Vote         1      
Authorized share capital (in shares)         700,000,000 700,000,000   46,000,000
Ordinary shares reserved for issuance (in shares)         31,932,902      
Percentage of outstanding shares         5.00%      
Common stock, shares issued under ESPP (in shares)         0      
Additional equity-based compensation plan | $         $ 66,584 $ 76,853 $ 128,740  
Payments of tax withholding for share based compensation | $         $ 3,804 $ 5,751 6,152  
Maximum [Member]                
Stock Option Plan [Abstract]                
Common stock, shares available for issuance under ESPP (in shares)         6,386,580      
Percentage of total outstanding shares on diluted basis in ESPP         2.00%      
Additional equity-based compensation plan | $ $ 50,000              
RSUs [Member]                
Stock Option Plan [Abstract]                
Net issuance of shares (in shares)         1,164,873      
RSUs [Member] | Time-Based Vesting Condition [Member]                
Stock Option Plan [Abstract]                
Vesting period         4 years      
RSUs [Member] | Vesting Condition [Member]                
Stock Option Plan [Abstract]                
Vesting period         5 years      
Share Options [Member]                
Stock Option Plan [Abstract]                
Vesting period         4 years      
Expiration period         10 years      
Outstanding Share Options [Roll Forward]                
Outstanding, beginning of period (in shares)     35,488,179   35,488,179      
Exercised (in shares)         (5,610,638)      
Forfeited (in shares)         (586,256)      
Outstanding, end of period (in shares)         29,291,285 35,488,179    
Exercisable (in shares)         24,738,145      
Weighted-Average Exercise Price [Roll Forward]                
Outstanding, beginning of period (in dollars per share) | $ / shares     $ 3.08   $ 3.08      
Exercised (in dollars per share) | $ / shares       $ 0 1.3      
Forfeited (in dollars per share) | $ / shares         5.91      
Outstanding, end of period (in dollars per share) | $ / shares         3.35 $ 3.08    
Exercisable (in dollars per share) | $ / shares         $ 2.78      
Weighted Average Remaining Contractual Term [Abstract]                
Weighted-average remaining contractual life         5 years 3 months 7 days 6 years 8 months 19 days    
Weighted-average remaining contractual life, exercisable         4 years 10 months 20 days      
Aggregate Intrinsic Value [Abstract]                
Aggregate intrinsic value, outstanding | $         $ 57,118 $ 40,516    
Aggregate intrinsic value, exercisable | $         $ 53,284      
Grant options (in shares)         0      
Ordinary Shares [Member]                
Stock Option Plan [Abstract]                
Net issuance of shares (in shares)   39,525,691     39,525,691      
Additional Paid-in Capital [Member]                
Stock Option Plan [Abstract]                
Additional equity-based compensation plan | $         $ 66,584 76,853 128,740  
Payments of tax withholding for share based compensation | $         $ 3,804 $ 5,751 $ 6,152  
Non-Voting Ordinary Shares [Member]                
Stock Option Plan [Abstract]                
Authorized share capital (in shares)         46,000,000 46,000,000    
Non-Voting Ordinary Shares [Member] | Ordinary Shares [Member]                
Stock Option Plan [Abstract]                
Net issuance of shares (in shares)   45,198,702 45,198,702   45,198,702